Factor21® (Bitter Melon Extract — Verdure Sciences)

Momordica charantia
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

Factor21® is a bitter melon (Momordica charantia) extract from Verdure Sciences, standardized to momordicosides. The FGF21 and AMPK claims behind the product name come from a mouse study of the company's bitter melon extract, not from human trials. Bitter melon is traditionally used for blood sugar support. The human evidence here is a meta-analysis of ordinary bitter melon preparations in people already diagnosed with type 2 diabetes; no human study has used Factor21 itself.

Studied Dose No dose has been established for this branded extract in human trials. The supplier suggests 100 to 500 mg a day.
Active Compound Bitter melon (Momordica charantia) extract standardized to momordicosides.

Benefits

Healthy blood sugar

A meta-analysis of eight trials in 423 people with type 2 diabetes found ordinary bitter melon preparations produced modest improvements in fasting glucose, post-meal glucose and HbA1c, with wide variation between trials. Everyone studied already had a diagnosis, insulin sensitivity was not measured, and none of the trials used Factor21.

Energy metabolism, animal data

The FGF21 and AMPK findings come from mice fed a high-fat diet for 12 weeks alongside a Verdure Sciences bitter melon extract. Liver AMPK and Sirt1 rose, while blood FGF21 fell and its receptors increased, which the authors read as better FGF21 sensitivity rather than more FGF21. No human study has measured FGF21 or AMPK with this extract.

Weight: not measured in the cited studies

Nothing cited here measured body weight, BMI, waist size or body fat. Pooled bitter melon trials that did measure them found no change, so there is no basis for a weight claim.

Mechanism of action

1

AMPK and FGF21 signaling, animal work only

In mice fed a high-fat diet, a bitter melon extract standardized to momordicosides raised liver AMPK and Sirt1 and altered FGF21 signaling. These are animal findings; the same pathways have not been measured in people.

2

Insulin-like glucose support

In laboratory studies, bitter melon compounds act on cellular glucose uptake. This is a proposed explanation from lab work, not something measured in the trials cited here.

Clinical trials

1
Bitter Melon and Glycemic Control — Meta-Analysis
PubMed

Systematic review and meta-analysis of eight randomized trials of ordinary bitter melon preparations in 423 patients with type 2 diabetes, covering glycemic control and blood fats. (Zhang et al. 2024, Heliyon)

423 adults with diagnosed type 2 diabetes, pooled from eight trials.

Fasting glucose fell 0.85 mmol/L, post-meal glucose 2.28 mmol/L, HbA1c 0.38 percentage points and total cholesterol 0.38 mmol/L. There was no effect on triglycerides, HDL or LDL. Results varied widely between trials and the authors call for further high-quality studies. Factor21 was not used in any of them; standardizing an extract to a marker compound does not make it the same as the mixed preparations pooled here.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated, though bitter melon seeds contain vicine, which can trigger favism, a form of hemolytic anemia, in people with G6PD deficiency.
Stomach upset, nausea and diarrhea are reported, more often with concentrated forms and juice.
May lower blood sugar, and the pooled trials show that lowering is real. Anyone taking insulin, sulfonylureas, metformin or another glucose-lowering drug should monitor closely and speak to the prescriber first.

Important Drug interactions

Diabetes medication — may add to blood-sugar lowering; monitor closely.
Tell your doctor if you take insulin or other glucose-lowering drugs.
Avoid in pregnancy. Bitter melon is traditionally used to bring on menstruation and to end pregnancy, and animal studies point to harm to the developing fetus. Safety while breastfeeding is not established.

Frequently asked questions about Factor21® (Bitter Melon Extract — Verdure Sciences)

What is Factor21?

Factor21® is a bitter melon (Momordica charantia) extract from Verdure Sciences, standardized to momordicosides. The FGF21 and AMPK claims behind the product name come from a mouse study of the company's bitter melon extract, not from human trials. Bitter melon is traditionally used for blood sugar support.

What is Factor21 used for?

Factor21 is researched primarily for Metabolic Health. A meta-analysis of eight trials in 423 people with type 2 diabetes found ordinary bitter melon preparations produced modest improvements in fasting glucose, post-meal glucose and HbA1c, with wide variation between trials.

What is the recommended dosage of Factor21?

The clinically studied dose is No dose has been established for this branded extract in human trials. The supplier suggests 100 to 500 mg a day. Always follow the product label and check with a healthcare provider for personal advice.

Is Factor21 safe, and does it have side effects?

For most healthy adults, Factor21 is well tolerated at studied doses. Reported effects can include: Generally well tolerated, though bitter melon seeds contain vicine, which can trigger favism, a form of hemolytic anemia, in people with G6PD deficiency. Stomach upset, nausea and diarrhea are reported, more often with concentrated forms and juice. It may also interact with some medications. Factor21 is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Factor21 interact with any medications?

Possible interactions include: Diabetes medication — may add to blood-sugar lowering; monitor closely. Tell your doctor if you take insulin or other glucose-lowering drugs. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Factor21?

NutraSmarts rates the evidence for Factor21 as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Zhang X, Zhao Y, Song Y, Miao M. Effects of Momordica charantia L. supplementation on glycemic control and lipid profile: a systematic review and meta-analysis. Heliyon. 2024;10(10):e31126..PubMedUsed to support: Meta-analysis of eight trials in 423 patients with type 2 diabetes reporting modest falls in fasting glucose, post-meal glucose, HbA1c and total cholesterol, with no effect on triglycerides, HDL or LDL and high heterogeneity. It did not test Factor21 or any branded extract, and it did not measure body weight, FGF21 or AMPK.